These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 20159899)

  • 21. Flunarizine-pizotifen single-dose double-blind cross-over trial in migraine prophylaxis.
    Cerbo R; Casacchia M; Formisano R; Feliciani M; Cusimano G; Buzzi MG; Agnoli A
    Cephalalgia; 1986 Mar; 6(1):15-8. PubMed ID: 3516406
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Flunarizine versus pizotifen: a double-blind study in the prophylaxis of migraine.
    Rascol A; Montastruc JL; Rascol O
    Headache; 1986 Feb; 26(2):83-5. PubMed ID: 3514549
    [No Abstract]   [Full Text] [Related]  

  • 23. A cooperative study on the clinical aspects of migraine and vascular headache and their response to sandomigran.
    Espadaler JM; Gimeno A; Lage AM
    Arch Neurobiol (Madr); 1974; 37 SUPPL():206-26. PubMed ID: 4462482
    [No Abstract]   [Full Text] [Related]  

  • 24. Botulinum toxin A for prophylactic treatment of migraine and tension headaches in adults: a meta-analysis.
    Jackson JL; Kuriyama A; Hayashino Y
    JAMA; 2012 Apr; 307(16):1736-45. PubMed ID: 22535858
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Botulinum toxin type A and acute drug costs in migraine with triptan overuse.
    Christie SN; Giammarco R; Gawel M; Mackie G; Gladstone J; Becker WJ
    Can J Neurol Sci; 2010 Sep; 37(5):588-94. PubMed ID: 21059503
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Therapy of migranes].
    Holle-Lee D; Nägel S; Gaul C
    Nervenarzt; 2017 Aug; 88(8):929-941. PubMed ID: 28497257
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preventive drugs in childhood and adolescent migraine.
    Kacperski J; Hershey AD
    Curr Pain Headache Rep; 2014 Jun; 18(6):422. PubMed ID: 24760491
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Botulinum Toxin versus Placebo: A Meta-Analysis of Prophylactic Treatment for Migraine.
    Bruloy E; Sinna R; Grolleau JL; Bout-Roumazeilles A; Berard E; Chaput B
    Plast Reconstr Surg; 2019 Jan; 143(1):239-250. PubMed ID: 30589800
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence-based medicine: botulinum toxin A in migraine and tension-type headache.
    Göbel H; Heinze A; Heinze-Kuhn K; Jost WH
    J Neurol; 2001 Apr; 248 Suppl 1():34-8. PubMed ID: 11357239
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Flunarizine, a calcium entry blocker in migraine prophylaxis.
    Amery WK; Caers LI; Aerts TJ
    Headache; 1985 Jul; 25(5):249-54. PubMed ID: 3897128
    [No Abstract]   [Full Text] [Related]  

  • 31. [Alternatives to beta blockers in preventive migraine treatment].
    Evers S
    Nervenarzt; 2008 Oct; 79(10):1135-6, 1138-40, 1142-3. PubMed ID: 18806984
    [TBL] [Abstract][Full Text] [Related]  

  • 32. OnabotulinumtoxinA for treatment of chronic migraine: PREEMPT 24-week pooled subgroup analysis of patients who had acute headache medication overuse at baseline.
    Silberstein SD; Blumenfeld AM; Cady RK; Turner IM; Lipton RB; Diener HC; Aurora SK; Sirimanne M; DeGryse RE; Turkel CC; Dodick DW
    J Neurol Sci; 2013 Aug; 331(1-2):48-56. PubMed ID: 23790235
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interventions for migraine prophylaxis: protocol of an umbrella systematic review and network meta-analysis.
    Zheng H; Chen M; Huang D; Li J; Chen Q; Fang J
    BMJ Open; 2015 May; 5(5):e007594. PubMed ID: 25948410
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Flunarizine in migraine prophylaxis: the clinical experience.
    Schmidt R; Oestreich W
    J Cardiovasc Pharmacol; 1991; 18 Suppl 8():S21-6. PubMed ID: 1726732
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Onset of action of various migraine prophylactics.
    Amery WK
    Cephalalgia; 1988; 8 Suppl 8():11-3. PubMed ID: 3180197
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Botulinum toxin type A (BOTOX) for treatment of migraine headaches: an open-label study.
    Binder WJ; Brin MF; Blitzer A; Schoenrock LD; Pogoda JM
    Otolaryngol Head Neck Surg; 2000 Dec; 123(6):669-76. PubMed ID: 11112955
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Practice parameter: pharmacological treatment of migraine headache in children and adolescents: report of the American Academy of Neurology Quality Standards Subcommittee and the Practice Committee of the Child Neurology Society.
    Lewis D; Ashwal S; Hershey A; Hirtz D; Yonker M; Silberstein S; ;
    Neurology; 2004 Dec; 63(12):2215-24. PubMed ID: 15623677
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Botulinum neurotoxin for the treatment of migraine and other primary headache disorders.
    Blumenfeld AM; Dodick DW; Silberstein SD
    Dermatol Clin; 2004 Apr; 22(2):167-75. PubMed ID: 15222577
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Flunarizine versus topiramate for chronic migraine prophylaxis: a randomized trial.
    Lai KL; Niddam DM; Fuh JL; Chen SP; Wang YF; Chen WT; Wu JC; Wang SJ
    Acta Neurol Scand; 2017 Apr; 135(4):476-483. PubMed ID: 27306581
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic migraine: a therapeutic challenge for clinicians.
    Irimia P; Carmona-Abellán M; Martínez-Vila E
    Expert Opin Emerg Drugs; 2012 Dec; 17(4):445-7. PubMed ID: 22998764
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.